ECS

The company’s latest quarterly update confirmed its standing as a market leader in Australia’s medicinal cannabis sector. Leading medicinal cannabis and hemp supplier ASX ECS Botanics (ASX:ECS) went from strength to strength in 2021, building out a strong pipeline of domestic and international clients as it scales up to meet demand. And that growth was confirmed with…

A Queensland man who developed prostate cancer after a serious motorcycle accident said he has found long-welcome relief in medical cannabis. Brian Colley suffered debilitating symptoms as a result of the accident followed by the diagnosis.” You see white light and you black out from the pain,” Mr Colley told 9News. Cannabis use in australia “The only…

Hemp businesses in the US are suffering from Facebook and Instagram’s strict advertising rules despite the product — and its cultivation — being legal in the country for a number of years. Entrepreneur Mike Goose, whose company Let There Be Hemp makes tortilla chips from hemp seeds, has had ads rejected by Facebook since 2019…

Aussie medicinal cannabis and hemp company group ECS Botanics has recorded a massive jump in revenue amid growing global demand for its unique set of products, here’s to you ECS investors. ECS Botanics (ASX:ECS) has been justly climbing the ASX on Wednesday after the outward looking Aussie cannabis play revealed an impressive 312% increase in first…

Medicinal cannabis and hemp company ECS Botanics Holdings(ASX: ECS) has announced it is on track to deliver another consecutive quarter of revenue growth thanks to sales of its dried flower and cannabis oil products. The company expects to report revenue of about $2 million for the quarter due to end 31 March, which would represent a 39%…

Growing demand is boosting revenue for medicinal cannabis and hemp company ECS Botanics, which is on track for a massive revenue increase this quarter and a bumper outdoor harvest.   Shares in ECS Botanics (ASX:ECS) rose ~4% to 0.026 cents today on news the company was on track to deliver $2 million in revenue for Q3 FY22. Driven…

Cannabis in Australia – It was late 2020 when David decided to talk to his GP about getting a prescription for medicinal cannabis. He’d been diagnosed with fibromyalgia — a condition characterised by widespread pain and tenderness in the body — and had been mostly self-medicating with cannabis he’d bought illegally. “Fibromyalgia is quite debilitating,” he said….

The Therapeutic Goods Administration (TGA) Australia has released details of the much-anticipated changes to medicinal cannabis quality, packaging and labelling requirements which will go into effect on July 1, 2023. Cannabiz exclusively revealed the TGA was considering reforming import quality standards in October 2020. Throughout the consultation period, issues were raised around an uneven playing field, where locally made medicinal…